Literature DB >> 20575002

Investigation of solution and vapor phase mediated phase transformation in thiamine hydrochloride.

Paroma Chakravarty1, Ramprakash Govindarajan, Raj Suryanarayanan.   

Abstract

Thiamine hydrochloride (THCl) can exist as an anhydrate (AH), a hemihydrate (HH) and as a nonstoichiometric hydrate (NSH) where the water content can range between 0 and approximately 1 mole of water per mole of THCl. We have investigated the NSH --> HH phase transformation, in the presence of microcrystalline cellulose (MCC), following (i) wet massing, (ii) fluid-bed granulation, and (iii) exposure to water vapor (40 degrees C/75% RH). Based on Raman spectroscopy (40 degrees C), wet massing of NSH alone caused near complete transformation to HH in <100 min. In the presence of MCC, the transformation rate was decelerated. During fluid-bed granulation, approximately 20% of NSH was transformed to HH and the deceleratory effect of MCC was much less pronounced. Exposure to water vapor, of both NSH-MCC powder blends and granules (prepared by fluid-bed) resulted in complete HH formation within 6 days. Presence of MCC in the powder blend did not affect HH formation kinetics, but facilitated phase transformation in the granules. NSH --> HH conversion appeared to follow two-dimensional nucleation and growth model in powder blends, whereas the granules showed either three-dimensional diffusion controlled or a first-order kinetics. In a wet mass, polyvinyl pyrrolidone, a widely used binder, was much more effective than MCC in inhibiting HH formation during wet massing.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20575002     DOI: 10.1002/jps.22240

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  1 in total

1.  Inhibition of the Vapor-Mediated Phase Transition of the High Temperature Form of Pyrazinamide.

Authors:  M M H Smets; G Baaklini; A Tijink; L Sweers; C H F Vossen; C Brandel; H Meekes; H M Cuppen; G Coquerel
Journal:  Cryst Growth Des       Date:  2017-12-28       Impact factor: 4.076

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.